Toggle light / dark theme

Step two of…

(Meanwhile in Bangladesh)


The ID2020 Alliance has launched a new digital identity program at its annual summit in New York, in collaboration with the Government of Bangladesh, vaccine alliance Gavi, and new partners in government, academia, and humanitarian relief.

The program to leverage immunization as an opportunity to establish digital identity was unveiled by ID2020 in partnership with the Bangladesh Government’s Access to Information (a2i) Program, the Directorate General of Health Services, and Gavi, according to the announcement.

Shane chats with former NSA spy and whistleblower Edward Snowden on the rise of authoritarianism during the COVID-19 pandemic.

About VICE:
The Definitive Guide To Enlightening Information. From every corner of the planet, our immersive, caustic, ground-breaking and often bizarre stories have changed the way people think about culture, crime, art, parties, fashion, protest, the internet and other subjects that don’t even have names yet. Browse the growing library and discover corners of the world you never knew existed. Welcome to VICE.

Connect with VICE:
Check out our full video catalog: http://bit.ly/VICE-Videos
Videos, daily editorial and more: http://vice.com
More videos from the VICE network: https://www.fb.com/vicevideo

Like VICE on Facebook: http://fb.com/vice
Follow VICE on Twitter: http://twitter.com/vice
Follow us on Instagram: http://instagram.com/vice

The VICE YouTube Network:
VICE: https://www.youtube.com/VICE
MUNCHIES: https://www.youtube.com/MUNCHIES
VICE News: https://www.youtube.com/VICENews
VICELAND: https://www.youtube.com/VICELANDTV
Broadly: https://www.youtube.com/Broadly
Noisey: https://www.youtube.com/Noisey
Motherboard: https://www.youtube.com/MotherboardTV
VICE Sports: https://www.youtube.com/NOC
i-D: https://www.youtube.com/iDmagazine
Waypoint: https://www.youtube.com/Waypoint

The role of automatic electrocardiogram (ECG) analysis in clinical practice is limited by the accuracy of existing models. Deep Neural Networks (DNNs) are models composed of stacked transformations that learn tasks by examples. This technology has recently achieved striking success in a variety of task and there are great expectations on how it might improve clinical practice. Here we present a DNN model trained in a dataset with more than 2 million labeled exams analyzed by the Telehealth Network of Minas Gerais and collected under the scope of the CODE (Clinical Outcomes in Digital Electrocardiology) study. The DNN outperform cardiology resident medical doctors in recognizing 6 types of abnormalities in 12-lead ECG recordings, with F1 scores above 80% and specificity over 99%. These results indicate ECG analysis based on DNNs, previously studied in a single-lead setup, generalizes well to 12-lead exams, taking the technology closer to the standard clinical practice.

Amid the coronavirus pandemic that has spread across the U.S., a number of states have extended their lockdown orders in an effort to combat the spread of the virus.

As of April 8, every U.S. state has reported confirmed coronavirus cases but the stay-at-home and shelter-in-place policies all came at different times. California was the first state to issue a stay-at-home order on March 19, while South Carolina was the most recent, issuing their statewide order on April 7. Some other states like Arkansas, Iowa, North Dakota and Nebraska have yet to issue statewide stay-at-home orders.

Researchers at the Hebrew University of Jerusalem announced on Sunday that they have developed a new method of testing for COVID-19 which is not only 4–10 times faster than the tests most commonly used today, but also significantly cheaper, while supplying the same level of accuracy. Moreover, most of the materials required to perform the new test are already available in Israel, easing significantly both the country’s dire shortage of testing materials and its heavy economic dependence on foreign commercial markets. The method was developed in the labs of Prof. Nir Friedman of the Institute of Life Sciences and the School of Engineering and Computer Sciences and Dr. Naomi Haviv of Hebrew University’s Neuroscience Research Center, and is based on materials which are not affected by global shortages and can be recycled for repeated used on future tests. The method commonly used today for COVID-19 testing involves extracting RNA molecules from a patient’s sample to determine if the molecules produced have viral RNA within them, which confirms the presence of the coronavirus. The new test developed by the researchers performs the same action, but is made from more commonly attainable materials, that produce results at a much higher speed. Dr. Naomi Haviv said that “We have an efficient RNA extraction method, 4–10 times faster than the current method. It is based on magnetic beads and can be performed both robotically and manually.”

Other than the magnetic beads, all of the other materials needed to perform the tests are available for purchase in Israel. The beads themselves are recyclable and can be reused to perform future tests. “The robotic method has already undergone a series of tests at Hadassah Hospital, using hundreds of samples from patients — and is now becoming operational.”


The new test would supply results 4–10 times faster than the current method, and is made almost entirely from materials which are easily available for purchase within the country.

At least 70 potential coronavirus vaccines are currently in development, with 3 already in clinical trials, according to the World Health Organisation.

WHO published an updated list of vaccine efforts on April 11, showing a vast array of companies pursuing shots that could halt the coronavirus. Bloomberg News reported on the document earlier.

As the virus continues to spread, infecting more than 1.9 million people and killing more than 110,000 worldwide, researchers have been racing to develop vaccines.

This is huge news… heart disease is the number one killer globally.

“They found that Myc-driven activity in heart muscle cells is critically dependent on the level of another protein called Cyclin T1, made by a gene called Ccnt1, within the cells. When the Ccnt1 and Myc genes are expressed together, the heart switches into a regenerative state and its cells start to replicate. The results are published today in the journal Nature Communications.”


Researchers trying to turn off a gene that allows cancers to spread have made a surprising U-turn. By making the gene overactive and functional in the hearts of mice, they have triggered heart cell regeneration. Since adult hearts cannot usually repair themselves once damaged, harnessing the power of this gene represents major progress towards the first curative treatment for heart disease.

“This is really exciting because scientists have been trying to make cells proliferate for a long time. None of the current treatments are able to reverse degeneration of the heart tissue—they only slow progression of the disease. Now we’ve found a way to do it in a ,” said Dr. Catherine Wilson, a researcher in the University of Cambridge’s Department of Pharmacology, who led the study.

The cell cycle—through which cells make copies of themselves—is tightly controlled in . Cancer develops when cells start to replicate themselves uncontrollably, and the Myc gene plays a key role in the process. Myc is known to be overactive in the vast majority of cancers, so targeting this gene is one of the highest priorities in cancer research. Much recent research has focused on trying to take control of Myc as a means of cancer therapy.